Prosperity Financial Group Inc. Invests $868,000 in Astera Labs, Inc. $ALAB

Prosperity Financial Group Inc. acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 5,215 shares of the company’s stock, valued at approximately $868,000.

Several other hedge funds have also modified their holdings of ALAB. Nordea Investment Management AB bought a new position in shares of Astera Labs during the 4th quarter valued at approximately $2,028,000. Geneva Partners LLC bought a new position in shares of Astera Labs during the 3rd quarter valued at approximately $1,876,000. Numerai GP LLC increased its position in shares of Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after purchasing an additional 7,992 shares during the last quarter. Handelsbanken Fonder AB increased its position in shares of Astera Labs by 289.5% during the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after purchasing an additional 93,800 shares during the last quarter. Finally, Corient Private Wealth LLC bought a new position in shares of Astera Labs during the 2nd quarter valued at approximately $543,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Astera Labs

In other news, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the transaction, the general counsel owned 118,084 shares of the company’s stock, valued at approximately $12,725,912.68. This represents a 7.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director directly owned 319,863 shares in the company, valued at $34,420,457.43. The trade was a 36.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 704,009 shares of company stock worth $88,536,187. Insiders own 12.50% of the company’s stock.

Astera Labs Stock Down 0.7%

Shares of Astera Labs stock opened at $170.81 on Friday. The stock’s fifty day moving average is $129.75 and its two-hundred day moving average is $154.53. The company has a market capitalization of $29.25 billion, a PE ratio of 140.01, a price-to-earnings-growth ratio of 3.39 and a beta of 1.78. Astera Labs, Inc. has a 52 week low of $52.56 and a 52 week high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. The company had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs’s quarterly revenue was up 91.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on ALAB shares. Royal Bank Of Canada started coverage on Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 target price on the stock. Weiss Ratings downgraded Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Loop Capital started coverage on Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 target price on the stock. Barclays set a $165.00 target price on Astera Labs in a research report on Thursday, January 15th. Finally, Citigroup assumed coverage on Astera Labs in a research report on Thursday, April 2nd. They set a “buy” rating and a $200.00 target price on the stock. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $199.44.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.